{"id":"W4398255879","doi":"10.1017/cjn.2024.92","title":"D.1 Efficacy, safety, and tolerability of subcutaneous efgartigimod in chronic inflammatory demyelinating polyneuropathy: results from the ADHERE trial","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Workers Compensation Board of Alberta","funders":"","keywords":"Medicine; Chronic inflammatory demyelinating polyneuropathy; Tolerability; Adverse effect; Placebo; Internal medicine; Randomized controlled trial; Multifocal motor neuropathy; Gastroenterology; Autoantibody; Antibody; Polyradiculoneuropathy; Clinical trial; Surgery; Immunology; Mismatch negativity; Pathology; Guillain-Barre syndrome","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.005610929,0.0002955153,0.0006496174,0.0005397066,0.000991656,0.0004018749,0.001168152,0.0001705991,0.00007472842],"category_scores_gemma":[0.008272955,0.0001738683,0.0002449235,0.001094859,0.006369357,0.0004498365,0.0001079329,0.001558897,0.000001585815],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004055891,"about_ca_system_score_gemma":0.008435135,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003342164,"about_ca_topic_score_gemma":0.05374533,"domain_scores_codex":[0.9948183,0.001225468,0.001616154,0.0005939546,0.000767531,0.000978627],"domain_scores_gemma":[0.9946154,0.003326961,0.0006673219,0.00022073,0.0002346337,0.0009349496],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02469779,0.0001534721,0.8658264,0.00007613419,0.00007960176,0.05092634,0.003357139,0.009401535,0.0003891697,0.001220317,0.0004785088,0.04339363],"study_design_scores_gemma":[0.008699085,0.1241938,0.807746,0.0007051909,0.000188846,0.03442562,0.0006229476,0.01052775,0.0001264094,0.008936967,0.003348564,0.0004788656],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9831087,0.008474003,0.000004834163,0.006791481,0.0006015664,0.0003768404,0.0000388556,0.00002071039,0.0005830381],"genre_scores_gemma":[0.9979582,0.0007452203,0.0001367716,0.0007541753,0.0003766518,0.000001802908,6.665115e-7,0.00001322293,0.00001327166],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1240403,"threshold_uncertainty_score":0.9971861,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02501606332799626,"score_gpt":0.276966499597633,"score_spread":0.2519504362696367,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}